Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2740-2746

  Vryonidou, Andromachi ^a,b,d   Papatheodorou, Athanasios ^b   Tavridou, Anna ^c   Terzi, Thomais ^b   Loi, Vasiliki ^b   Vatalas, Ioannis Anastasios ^b   Batakis, Nikolaos ^b   Phenekos, Constantinos ^b   Dionyssiou Asteriou, Amalia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; STROKE;

ADOLESCENT; ADULT; BODY MASS INDEX; CAROTID ARTERIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYPERANDROGENISM; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TUNICA INTIMA;

EID: 18844408055     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2363     Document Type: Article

References (69)

1. Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897-1899
2. Book CB, Dunaif A 1999 Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 87:3110-3116
3. Dunaif A, Thomas A 2001 Current concepts in the polycystic ovary syndrome. Annu Rev Med 52:401-419
4. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
6. Talbott E, Clerici A, Berga S, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA 1998 Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51:415-422
7. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS 1992 Risk factors for coronary heart disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37:119-125
8. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N 2001 Low-grade inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453-2455
9. Escobar-Morreale HF, Botella-Carretero J, Villuendas G, Sancho J, San Millan J 2004 Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 89:806-811
10. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R 2003 Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 18:721-727
11. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard M, Baron A 2001 Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410-1415
12. Orio F, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G, Colao A 2004 Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:4588-4593
13. Sam S, Dunaif A 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365-370
14. Talbott E, Guzick D, Sutton-Tyrrell K, McHugh-Pemu K, Zborowski J, Remsberg K, Kuller L 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
15. Christian R, Dumesic D, Behrenbeck T, Oberg A, Sheedy P, Fitzpatrick L 2003 Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
16. Salonen JT, Salonen R 1991 Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11:1245-1249
17. O'Leary DH, Polak JK, Kronmal RA, Manolio TA, Burke GL, Wolfson SK 1999 Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22
18. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R, Muggeo M 2003 Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 26:1251-1257
19. Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J 2000 Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15:785-789
20. Birdsall MA, Farquhar CM, White HD 1997 Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32-35
21. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604
22. Pierpoint T, McKeigue PM, Isaacs AJ, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
23. Wild S, Pierpoint T, McKeigue PM, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
24. Guzick DS 2004 Cardiovascular risk in PCOS. J Clin Endocrinol Metab 89:3694-3695
25. Legro RS 2003 Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302-312
26. Escobar-Morreale H, Asuncion M, Calvo R, Sancho J, San Millan J 2001 Receiver operator characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 145:619-624
27. National Institutes of Health 1998 Clinical Guidelines on the Evaluation and Treatment of Overweight and Obesity in Adults: the Evidence Report. Obes Res 6(Suppl 2):51S-209S
28. Ferriman D, Gallwey J 1961 Clinical assessment of body hair growth in women. Clin Endocrinol (Oxf) 21:1440-1445
29. Haluska BA, Fathi R, Jefriess L, Leano R, Carlier S, Marwick T 2004 Non-invasive tests for arterial structure, function and compliance: do they identify risk or diagnose disease. J Am Soc Echocardiogr 17:195-202
30. O'Leary DH, Polak JK 2002 Intima-media thickness: a total for atherosclerosis imaging and event prediction. Am J Cardiol 90:18L-21L
31. Fallo F, Camporese G, Capitelli E, Andreozzi GM, Mantero F, Lumachi F 2003 Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 88:2096-2099
32. Barth JD 2002 An update on carotid ultrasound measurement of intima-media thickness. Am J Cardiol 89(4A):10B-15B
33. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
34. Graf M, Richards C, Brown V, Meissner L, Dunaif A 1990 The independent effects of hyperandrogenaemia, hyperinsulinaemia and obesity on lipid and lipoprotein profiles in women. Clin Endocrinol (Oxf) 33:119-131
35. Robinson S, Henderson A, Gelding S, Kiddy D, Niththyananthan R, Bush A, Johnston D, Franks S 1996 Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) 44:277-284
36. Legro R, Kunselman A, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607-613
37. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Grouse JR 1990 Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis. Circulation 82:1230-1242
38. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes R, Rosamond W, Crow RS, Rautaharju PM, Heiss G 1995 Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 26:386-391
39. Allan PL, Mowbray PI, Lee AJ, Fowkes FG 1997 Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke 28:348-353
40. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE 1997 Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432-1437
41. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD 1999 Carotid plaque, intima media thickness, cardiovascular risk factors and prevalent disease in men and women: the British Regional Heart Study. Stroke 30:841-850
42. Howard G, Manolio TA, Burke GL, Wolfson SK, O'Leary DH 1997 Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. Stroke 28:1693-1701
43. Mannami T, Konishi M, Baba S, Nishi N, Terao A 1997 Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita Study. Stroke 1997 28:518-525
44. Berenson GS, Srinivasan SR, Bao W, Newman W, Tracy R, Wattigney W 1998 Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults for the Bogalusa Heart Study. N Engl J Med 338:1650-1656
45. Davis P, Dawson J, Riley W, Lauer R 2001 Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104:2815-2819
46. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, Bonaa KH 1996 Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 16:984-991
47. Pauletto P, Palatini P, Da Ros S, Pagliara V, Santipolo N, Baccillieri S, Casiglia E, Mormino P, Pessina A 1999 Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 19:1231-1237
48. Jarvisalo M, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, Raitakari O 2002 Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 51:493-498
49. Wang T, Nam B, D'Agostino R, Wolf P, Lloyd-Jones D, MacRae C, Wilson P, Polak J, O'Donnell C 2003 Carotid intima-media thickness is associated with parental premature coronary heart disease: the Framingham Heart Study. Circulation 108:572-577
50. Mosca L, Manson J, Sutherland S, Langer R, Manolio T, Barrett-Connor E 1997 Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 96:2468-2482
51. Liu P, Death A, Handelsman D 2003 Androgens and cardiovascular disease. Endocr Rev 24:313-340
52. Ibanez L, Vails C, Markos M-V, Ong K, Dunger D, De Zegher F 2004 Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and posrpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 89:4331-4337
53. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
54. Sepilian V, Nagamani M 2005 Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 90:60-65
55. Vatalas I-A, Dionyssiou-Asteriou A 2001 Adrenal C19 steroids and serum lipoprotein levels in healthy men. Nutr Metab Cardiovasc Dis 11:388-393
56. Khalil A, Fortin JP, LeHoux JG, Fulop T 2000 Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation. J Lipid Res 41:1552-1561
57. Barrett-Connor E, Goodman-Gruen D 1995 The epidemiology of DHEAS and cardiovascular disease. Ann NY Acad Sci 774:259-270
58. Simoncini T, Manella P, Fornari L, Varone G, Caruso A, Genazzani A 2003 Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinol 144:3449-3455
59. Waxman DJ 1996 Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. Eur J Endocrinol 150:5129-5147
60. Dillon J, Yaney G, Zhou Y, Voilley N, Bowen S, Chipkin S, Bliss C, Schoultz V, Schuit F, Prentki M, Waxman D, Corkey B 2000 Dehydroepiandrosterone sulfate and β-cell function. Diabetes 49:2012-2020
61. Slowinska-Srzednicka J, Malczewska B, Srzednicki M, Chotkowska E, Zgliczynski W, Osowski M, Jeske W, Zgliczynski S, Sadowski Z 1995 Hyperinsulinemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med 237:465-472
62. Kaczmarek A, Reczuch K, Majda J, Banaciak W, Ponikowski P 2003 The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol 87:53-57
63. Bernini G, Sgro' M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, Salvetti A 1999 Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84:2008-2012
64. Bernini G, Moretti A, Sgro' M, Argenio G, Barlascini C, Cristofani R, Salvetti A 2001 Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 8:43-50
65. Golden SH, Maguire A, Ding J, Crouse J, Cauley J, Zacur H, Szklo M 2002 Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 155:437-445
66. Legro R, Bentley-Lewis R, Driscoll D, Wang S, Dunaif A 2002 Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87:2128-2133
67. Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos J, Perez-Bravo E 2002 Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45:959-964
68. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
69. Pannacciulli N, De Pergola G, Ciccone M, Rizzon P, Giorgino F, Giorgino R 2003 Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care 26:1230-1234